These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1743004)

  • 1. A computer program for randomizing patients with near-even distribution of important parameters.
    Jensen CV
    Comput Biomed Res; 1991 Oct; 24(5):429-34. PubMed ID: 1743004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized multidimensional dynamic allocation method.
    Lebowitsch J; Ge Y; Young B; Hu F
    Stat Med; 2012 Dec; 31(28):3537-44. PubMed ID: 22736449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTS: a clinical trials simulator.
    Taylor DW; Bosch EG
    Stat Med; 1990 Jul; 9(7):787-801. PubMed ID: 2218181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A computer program for sample size and power calculations in the design of multi-arm and factorial clinical trials with survival time endpoints.
    Natarajan R; Turnbull BW; Slate EH; Clark LC
    Comput Methods Programs Biomed; 1996 Mar; 49(2):137-47. PubMed ID: 8735021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing for cancer clinical trials: selection of prognostic factors.
    Brown BW
    Cancer Treat Rep; 1980; 64(2-3):499-502. PubMed ID: 7407790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Randomization for controlled therapeutic trials].
    Schemper M
    Wien Klin Wochenschr; 1982 Nov; 94(22):604-9. PubMed ID: 7164464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PODSE: a computer program for optimal design of trials with discrete-time survival endpoints.
    Jóźwiak K; Moerbeek M
    Comput Methods Programs Biomed; 2013 Jul; 111(1):115-27. PubMed ID: 23578981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials simulation: a statistical approach.
    Westfall PH; Tsai K; Ogenstad S; Tomoiaga A; Moseley S; Lu Y
    J Biopharm Stat; 2008; 18(4):611-30. PubMed ID: 18607794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomisation to protect against selection bias in healthcare trials.
    Kunz R; Vist G; Oxman AD
    Cochrane Database Syst Rev; 2007 Apr; (2):MR000012. PubMed ID: 17443633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Design consideration for clinical trials].
    Flemming TR
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):568-73. PubMed ID: 3355178
    [No Abstract]   [Full Text] [Related]  

  • 11. EasyMA: a program for the meta-analysis of clinical trials.
    Cucherat M; Boissel JP; Leizorovicz A; Haugh MC
    Comput Methods Programs Biomed; 1997 Jul; 53(3):187-90. PubMed ID: 9230453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomization in cancer clinical trials: permutation test and development of a computer program.
    Ohashi Y
    Environ Health Perspect; 1990 Jul; 87():13-7. PubMed ID: 2269216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An easily customized, random allocation system using the minimization method for multi-institutional clinical trials.
    Kenjo Y; Antoku Y; Akazawa K; Hanada E; Kinukawa N; Nose Y
    Comput Methods Programs Biomed; 2000 May; 62(1):45-9. PubMed ID: 10699684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials--time for a paradigm shift?
    Bradley C
    Diabet Med; 1988 Mar; 5(2):107-9. PubMed ID: 2964973
    [No Abstract]   [Full Text] [Related]  

  • 15. Minimization--a method of obtaining comparable groups in clinical trials.
    Weis OF; Luus HG; Müller FO
    S Afr Med J; 1984 Aug; 66(5):180-2. PubMed ID: 6463794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simulation program for estimating statistical power of Cox's proportional hazards model assuming no specific distribution for the survival time.
    Akazawa K; Nakamura T; Moriguchi S; Shimada M; Nose Y
    Comput Methods Programs Biomed; 1991 Jul; 35(3):203-12. PubMed ID: 1935013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the Bayesian dynamic survival model in medicine.
    He J; McGee DL; Niu X
    Stat Med; 2010 Feb; 29(3):347-60. PubMed ID: 20014356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of clinical trials.
    Jackson RR
    Postgrad Med J; 1985 Feb; 61(712):133-9. PubMed ID: 3983040
    [No Abstract]   [Full Text] [Related]  

  • 19. Detecting data fabrication in clinical trials from cluster analysis perspective.
    Wu X; Carlsson M
    Pharm Stat; 2011; 10(3):257-64. PubMed ID: 20936626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A C++ program to calculate sample sizes for cost-effectiveness trials in a Bayesian framework.
    Sarker SJ; Whitehead A; Khan I
    Comput Methods Programs Biomed; 2013 Jun; 110(3):471-89. PubMed ID: 23399102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.